Shenyang Northern Hospital

This large study aims to find out which of two common blood thinners is safer for heart attack patients who are also at high risk of bleeding. It will compare bivalirudin against heparin in over 5,000 patients in China during a procedure to open blocked heart arteries. The main g…

This study aims to find out if adding an extra step to a standard heart ablation procedure works better for people with persistent atrial fibrillation (AFib). It will compare the standard procedure (pulmonary vein isolation) against the standard procedure plus ablation of a speci…

This study is testing if a low-dose anti-inflammatory drug (colchicine) can slow the progression of coronary artery plaque in people who have recently had a heart attack. It specifically aims to see if the drug works better for patients who have a certain genetic marker called TE…

This study is for people who have had a heart attack and received a stent, but are at high risk for both future clots and serious bleeding. It will test if using a special stent and only one month of strong blood thinners is as safe and effective as using standard stents with a f…

This study is testing if a drug called dapagliflozin, usually used for diabetes, can reduce harmful inflammation in the heart arteries of people who have recently had a heart attack. The 110 participants do not have diabetes or heart failure. Researchers will use special heart CT…

This study aims to understand and improve the real-world use of dual blood-thinning therapy (DAPT) in patients who have had a heart attack and received a stent. It will follow 3,500 patients at high risk for bleeding for one year to see how their treatment is managed and to test …